SBC / revenue moved 1422 bp lower
SBC / revenue changed -1422 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed -1422 basis points from the comparable as-filed period.
Stock-based compensation changed +31.1% from the comparable as-filed period.
Working capital changed -26.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net debt changed -29.1% from the comparable as-filed period.
Receivables / revenue changed +359 basis points from the comparable as-filed period.
Capital expenditure changed +132.6% from the comparable as-filed period.
R&D / revenue changed -7949 basis points from the comparable as-filed period.
Operating cash-flow margin changed +14744 basis points from the comparable as-filed period.
Free-cash-flow margin changed +14806 basis points from the comparable as-filed period.
Debt / revenue changed -27986 basis points from the comparable as-filed period.
Cash / debt changed +1130 basis points from the comparable as-filed period.
Current assets changed -11.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Capex / revenue changed -63 basis points from the comparable as-filed period.
Total assets changed -5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / assets changed +140 basis points from the comparable as-filed period.
Noncurrent long-term debt changed +1.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
SBC / revenue changed -3031 basis points from the comparable as-filed period.
Total assets changed -15.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed +18.5% from the comparable as-filed period.
R&D / revenue changed -11560 basis points from the comparable as-filed period.
Operating cash-flow margin changed +17050 basis points from the comparable as-filed period.
Net debt changed +100.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +17227 basis points from the comparable as-filed period.
Debt / revenue changed -38052 basis points from the comparable as-filed period.
Capex / revenue changed -177 basis points from the comparable as-filed period.
Capital expenditure changed +79.6% from the comparable as-filed period.
Shares outstanding changed +3.3% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Noncurrent long-term debt changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -4.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -63 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.